De novo design of new chemical entities for SARS-CoV-2 using artificial intelligence.
Reads0
Chats0
TLDR
De Novo Design of New Chemical Entities (NCEs) for SARS-CoV-2 Using Artificial IntelligenceAbstract:
Background: The novel coronavirus SARS-CoV-2 has severely affected the health and economy of several countries. Multiple studies are in progress to design novel therapeutics against the potential target proteins in SARS-CoV-2, including 3CL protease, an essential protein for virus replication. Materials & methods: In this study we employed deep neural network-based generative and predictive models for de novo design of small molecules capable of inhibiting the 3CL protease. The generative model was optimized using transfer learning and reinforcement learning to focus around the chemical space corresponding to the protease inhibitors. Multiple physicochemical property filters and virtual screening score were used for the final screening. Conclusion: We have identified 33 potential compounds as ideal candidates for further synthesis and testing against SARS-CoV-2.read more
Citations
More filters
Journal ArticleDOI
Mapping the landscape of artificial intelligence applications against COVID-19
Joseph Bullock,Alexandra Luccioni,Katherine Hoffmann Pham,Cynthia Sin Nga Lam,Miguel Luengo-Oroz +4 more
TL;DR: In this paper, the authors present an overview of recent studies using Machine Learning and Artificial Intelligence to tackle many aspects of the COVID-19 crisis and highlight the need for international cooperation to maximize the potential of AI in this and future pandemics.
Journal ArticleDOI
Leveraging Data Science to Combat COVID-19: A Comprehensive Review
Siddique Latif,Muhammad Usman,Sanaullah Manzoor,Waleed Iqbal,Junaid Qadir,Gareth Tyson,Ignacio Castro,Adeel Razi,Maged N. Kamel Boulos,Adrian Weller,Jon Crowcroft +10 more
TL;DR: This paper attempts to systematise the various COVID-19 research activities leveraging data science, where data science is defined broadly to encompass the various methods and tools that can be used to store, process, and extract insights from data.
Posted ContentDOI
Artificial Intelligence in the Battle against Coronavirus (COVID-19): A Survey and Future Research Directions
TL;DR: A survey of AI methods being used in various applications in the fight against the COVID-19 outbreak is presented and the crucial roles of AI research in this unprecedented battle are outlined.
Journal ArticleDOI
Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development
Arash Keshavarzi Arshadi,Julia Webb,Milad Salem,Emmanuel Cruz,Stacie Calad-Thomson,Niloofar Ghadirian,Jennifer Collins,Elena Diez-Cecilia,Brendan Kelly,Hani Goodarzi,Jiann-Shiun Yuan +10 more
TL;DR: To facilitate applications of deep learning for SARS-COV-2, multiple molecular targets of COVID-19 are highlighted, one of which may increase patient survival, and CoronaDB-AI, a dataset of compounds, peptides, and epitopes discovered either in silico or in vitro that can be potentially used for training models in order to extract CO VID-19 treatment.
Journal ArticleDOI
Mapping the Landscape of Artificial Intelligence Applications against COVID-19
Joseph Bullock,Alexandra Luccioni,Katherine Hoffmann Pham,Cynthia Sin Nga Lam,Miguel Luengo-Oroz +4 more
TL;DR: An overview of recent studies using Machine Learning and, more broadly, Artificial Intelligence to tackle many aspects of the COVID-19 crisis at different scales including molecular, clinical, and societal applications is presented.
References
More filters
Book
Reinforcement Learning: An Introduction
TL;DR: This book provides a clear and simple account of the key ideas and algorithms of reinforcement learning, which ranges from the history of the field's intellectual foundations to the most recent developments and applications.
Journal ArticleDOI
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang,Yeming Wang,Xingwang Li,Lili Ren,Jianping Zhao,Yi Hu,Li Zhang,Guohui Fan,Jiuyang Xu,Xiaoying Gu,Zhenshun Cheng,Ting Yu,Jia'an Xia,Yuan Wei,Wenjuan Wu,Xuelei Xie,Wen Yin,Li Hui,Min Liu,Yan Xiao,Hong Gao,Li Guo,Jungang Xie,Guang-Fa Wang,Rongmeng Jiang,Zhancheng Gao,Qi Jin,Jianwei Wang,Bin Cao +28 more
TL;DR: The epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of patients with laboratory-confirmed 2019-nCoV infection in Wuhan, China, were reported.
Journal ArticleDOI
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
Oleg Trott,Arthur J. Olson +1 more
TL;DR: AutoDock Vina achieves an approximately two orders of magnitude speed‐up compared with the molecular docking software previously developed in the lab, while also significantly improving the accuracy of the binding mode predictions, judging by tests on the training set used in AutoDock 4 development.
Journal ArticleDOI
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou,Xing-Lou Yang,Xian Guang Wang,Ben Hu,Lei Zhang,Wei Zhang,Hao Rui Si,Yan Zhu,Bei Li,Chao Lin Huang,Hui-Dong Chen,Jing Chen,Yun Luo,Hua Guo,Ren Di Jiang,Meiqin Liu,Ying Chen,Xu Rui Shen,Xi Wang,Xiao Shuang Zheng,Kai Zhao,Quanjiao Chen,Fei Deng,Lin Lin Liu,Bing Yan,Fa Xian Zhan,Yan-Yi Wang,Gengfu Xiao,Zhengli Shi +28 more
TL;DR: Identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China, and it is shown that this virus belongs to the species of SARSr-CoV, indicates that the virus is related to a bat coronav virus.
Journal ArticleDOI
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann,Hannah Kleine-Weber,Simon Schroeder,Nadine Krüger,Tanja Herrler,Sandra Erichsen,Tobias S. Schiergens,Georg Herrler,Nai Huei Wu,Andreas Nitsche,Marcel A. Müller,Christian Drosten,Christian Drosten,Stefan Pöhlmann +13 more
TL;DR: It is demonstrated that SARS-CoV-2 uses the SARS -CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming, and it is shown that the sera from convalescent SARS patients cross-neutralized Sars-2-S-driven entry.